Deep Track Capital, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001856083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2024 · 68 positions · Total reported value $3.35B · Top-10 concentration 41.7% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 59.3% · 18 new · 15 cut · 15 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +27.7% · vs SPY +12.9% · Prev Value $6.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2024 13F filing, Deep Track Capital, LP disclosed 68 equity positions with a combined reported value of $3.35B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 41.7% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were AMGN ($179.66M), ARGX ($172.02M), AXSM ($149.15M). By sector, the heaviest allocations are Health Care 78.3%, Other 21.7%. Versus the prior quarter, allocation shifted toward Health Care (+3.5pp) and away from Industrials (-0.8pp), Other (-2.8pp).

Versus the prior quarter, Deep Track Capital, LP opened 18 new positions, trimmed 15 and fully exited 15, a turnover rate of 59.3% of positions. The portfolio's overlap with the prior quarter was 77% of names.

The largest new positions opened in Q2 2024 were TGTX ($51.06M), CLYM ($27.76M), KRRO ($26.10M).

Of the 15 positions fully exited versus the prior quarter, the largest were TRML ($36.53M), PACB ($26.25M), NUVL ($20.61M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • TGTX TG THERAPEUTICS · $51.06M
  • CLYM CLIMB BIO INC · $27.76M
  • KRRO KORRO BIO INC · $26.10M
  • ETNB 89BIO INC · $18.38M
  • INO INOVIO PHARMACEUTICALS · $16.70M
  • PRAX PRAXIS PRECISION MEDICINES I · $16.11M
  • CNTX CONTEXT THERAPEUTICS INC · $14.88M
  • KURA KURA ONCOLOGY INC · $7.92M

Fully Exited (vs previous quarter)

  • TRML TOURMALINE BIO INC · prev qtr: $36.53M
  • PACB PACIFIC BIOSCIENCES CALIF IN · prev qtr: $26.25M
  • NUVL NUVALENT INC · prev qtr: $20.61M · history
  • ANAB ANAPTYSBIO INC COM · prev qtr: $11.92M
  • RARE ULTRAGENYX PHARMACEUTICAL IN · prev qtr: $7.83M
  • MRSN MERSANA THERAPEUTICS INC · prev qtr: $2.60M
  • PRME PRIME MEDICINE INC · prev qtr: $2.13M

Insider Transactions (Form 4)

Latest Deep Track Capital, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 1,957,138 — SEC filing

All insider transactions →

Fund Profile

Deep Track Capital, LP is an SEC-registered 13F filer based in Greenwich, CT, United States. As of Q2 2026 it reported 66 US equity positions with a combined value of $6.72B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-120500 (status: Approved), registered 2021-03-12
  • Regulatory AUM (Form ADV): $8.37B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: deeptrackcapital.com

Portfolio Structure

  • 66 positions · $6.72B reported value (Q2 2026)
  • Top 10 holdings = 40.5% of reported value
  • Largest position: GH (GUARDANT HEALTH INC) at 7.6%
  • Average position size: $101.75M

Sector Tilt

  • Health Care 95.4%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q2 2026: 18 new, 20 added, 15 reduced, 15 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 78.3%
Other 21.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 575.00K $179.66M 5.36%
5.36%
Add
2 400.00K $172.02M 5.13%
5.13%
Add
3 1.85M $149.15M 4.45%
4.45%
Add
4 4.00M $141.16M 4.21%
4.21%
Reduce
5 3.70M $139.38M 4.16%
4.16%
Add
6 2.00M $134.00M 4.00%
4.00%
Reduce
7 4.50M $129.96M 3.88%
3.88%
Reduce
8 10.90M $122.41M 3.65%
3.65%
Add
9 500.00K $121.50M 3.63%
3.63%
Reduce
10 4.80M $107.42M 3.21%
3.21%
Add
11 1.54M $105.33M 3.14%
3.14%
Add
12 2.50M $95.90M 2.86%
2.86%
Add
13 2.00M $95.32M 2.85%
2.85%
Add
14 12.72M $87.01M 2.60%
2.60%
Hold
15 4.06M $85.25M 2.54%
2.54%
Add
16 3.50M $84.35M 2.52%
2.52%
Hold
17 3.99M $83.30M 2.49%
2.49%
Add
18 2.88M $76.13M 2.27%
2.27%
Add
19 3.49M $70.65M 2.11%
2.11%
Hold
20 5.97M $64.20M 1.92%
1.92%
Add
21 7.37M $60.58M 1.81%
1.81%
Hold
22 4.00M $57.84M 1.73%
1.73%
Add
23 4.18M $55.26M 1.65%
1.65%
Reduce
24 13.00M $55.12M 1.65%
1.65%
Reduce
25 15.27M $53.15M 1.59%
1.59%
Hold
26 2.87M $51.06M 1.52%
1.52%
New
27 3.92M $51.05M 1.52%
1.52%
Add
28 1.50M $44.77M 1.34%
1.34%
Add
29 6.10M $44.01M 1.31%
1.31%
Reduce
30 4.00M $43.28M 1.29%
1.29%
Add
31 6.10M $41.54M 1.24%
1.24%
Hold
32 1.76M $41.30M 1.23%
1.23%
Add
33 1.00M $39.35M 1.17%
1.17%
Reduce
34 950.00K $37.31M 1.11%
1.11%
Add
35 466.09K $29.68M 0.89%
0.89%
Reduce
36 6.00M $28.02M 0.84%
0.84%
Add
37 3.90M $27.76M 0.83%
0.83%
New
38 1.83M $26.50M 0.79%
0.79%
Reduce
39 770.64K $26.10M 0.78%
0.78%
New
40 1.36M $25.84M 0.77%
0.77%
Reduce
41 17.88M $22.17M 0.66%
0.66%
Reduce
42 2.25M $21.22M 0.63%
0.63%
Hold
43 4.63M $21.03M 0.63%
0.63%
Add
44 2.29M $18.38M 0.55%
0.55%
New
45 5.57M $18.28M 0.55%
0.55%
Hold
46 2.07M $16.70M 0.50%
0.50%
New
47 389.55K $16.11M 0.48%
0.48%
New
48 58.14M $15.76M 0.47%
0.47%
Hold
49 7.42M $14.88M 0.44%
0.44%
New
50 4.18M $13.85M 0.41%
0.41%
Hold

FAQ

What did Deep Track Capital, LP buy in 2024-Q2?

In its 2024-Q2 13F filing, Deep Track Capital, LP reported 68 equity positions worth $3.35B in aggregate; its largest disclosed positions were AMGN ($179.66M), ARGX ($172.02M), AXSM ($149.15M).

How large is Deep Track Capital, LP's portfolio?

Deep Track Capital, LP reported $3.35B of long equity holdings across 68 positions as of 2024-Q2. Top-10 holdings account for 41.7% of reported value.

What is Deep Track Capital, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/deep-track-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →